Photo from Envato
Thanks to treatment advancements and better healthcare access.
The liver fibrosis market is projected to expand at a compound annual growth rate of 24% until 2034, according to a DelveInsight report.
The sector is driven by advancements in treatment options, better healthcare access, and an increasing prevalence of liver fibrosis.
“Treatments include biological and pharmacological therapies, lifestyle and dietary changes, and surgical interventions, all aimed at halting disease progression and preserving liver function,” the report said.
Meanwhile, key therapeutic targets include fibrogenic pathways, antiviral therapies, FXR agonists, and metabolic modulators to reduce inflammation and fibrosis.
Join
Healthcare Asia Magazine
community
Since you’re here…
…there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.
We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.
Let us help you drive your business forward with a good partnership!
